REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,576 | -24.9% | 35,200 | -20.0% | 0.00% | – |
Q2 2023 | $64,680 | +87.0% | 44,000 | +8.1% | 0.00% | – |
Q1 2023 | $34,595 | -40.4% | 40,700 | -4.0% | 0.00% | – |
Q4 2022 | $58,088 | -10.6% | 42,400 | +10.1% | 0.00% | – |
Q3 2022 | $65,000 | +35.4% | 38,500 | +65.9% | 0.00% | – |
Q2 2022 | $48,000 | – | 23,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 555,555 | $1,150,000 | 0.31% |
Ikarian Capital, LLC | 105,341 | $217,000 | 0.04% |
Sarissa Capital Management LP | 185,183 | $383,000 | 0.04% |
FEDERATED HERMES, INC. | 2,904,826 | $6,013,000 | 0.02% |
Virtu Financial LLC | 10,205 | $21,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 221,506 | $459,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 11,583 | $24,000 | 0.00% |
VANGUARD GROUP INC | 372,732 | $772,000 | 0.00% |
UBS Group AG | 8,252 | $17,000 | 0.00% |
Community Bank, N.A. | 690 | $1,000 | 0.00% |